ANGIOSAFE (CARDIOVASCULAR COALITION)

Lobbying client · California · filed 2026 to 2026

Manufacturer of products to treat peripheral artery disease.

$0 Reported spend

3 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 3 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (71252), not by name.

Firms hired 1

LIBERTY PARTNERS GROUP, LLC $0 3 filings

Bills named in these filings 2

HR 307
ARC Act of 2025

1 filing
HR 7863
Promoting Fairness for Medicare Providers Act of 2026

1 filing

Reported by year 1 year

2026 $0 3 filings

Issues lobbied 2

Health Issues 3
Medicare/Medicaid 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Centers For Medicare and Medicaid Services (CMS) 2
Health & Human Services, Dept of (HHS) 2
HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 4 total

2A

LIBERTY PARTNERS GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · posted Jul 20, 2026

View → Q2

LIBERTY PARTNERS GROUP, LLC Amended

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · posted Jul 20, 2026

View → Q1

LIBERTY PARTNERS GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 17, 2026

View → RR

LIBERTY PARTNERS GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · posted Feb 13, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.